Zepbound coverage in Canada is the part that trips up almost everyone, so here is the straight answer up front: no provincial public plan pays for Zepbound when the prescription is for weight loss, and only about 31% of employer private plans do, nearly always with prior authorization [1]. That gap is why so many Canadians pay cash. This page breaks down why coverage is so limited, what the public and private plans actually do, how prior authorization works step by step, and how to fight a denial. Numbers here are for planning; confirm the specifics with your own insurer.
Want the price picture too? Our Zepbound cost guide lists every dose price, and the Zepbound hub ties the whole topic together.
Why Coverage Is Complicated
Here is the root of the problem. Zepbound carries a weight-loss label, and Canadian public drug plans have long treated weight-loss drugs as lifestyle products rather than medical necessities. That framing has not caught up to the science of obesity as a chronic disease. So while a diabetes drug can win a public listing, the same molecule with a weight-loss label often cannot. Zepbound is tirzepatide, the same active ingredient as Mounjaro, but Mounjaro wears the type 2 diabetes label and Zepbound wears the obesity one. That single distinction decides who pays.
Private plans are catching up faster than public ones, but they hedge with prior authorization and dollar caps. The result is a patchwork where two people with the same prescription can pay wildly different amounts based only on their employer's benefits booklet.
Provincial Drug Plan Coverage
No provincial public plan in Canada covers Zepbound for weight loss as of mid-2026. Ontario's ODB, BC PharmaCare, Alberta's public plans, and Quebec's RAMQ all exclude weight-loss-only indications. If you are on a provincial plan and hoping it covers a weight-loss prescription, the honest answer today is that it does not.
One file is worth watching. BC PharmaCare has Zepbound formally under review as tirzepatide submission 4166, with the outcome still pending [2]. A positive decision there would be the first public listing for the drug in the country, so British Columbia residents should keep an eye on that submission. It is not coverage yet, and there is no promised date, so plan your budget as if it will not land this year.
Private Insurance Coverage
This is where the wins happen. About 31% of Canadian employer plans include some GLP-1 weight-loss coverage, so roughly one in three working Canadians has a shot at partial or full coverage [1]. Plans that cover it almost always require prior authorization, and the criteria usually mirror the drug label: a body mass index of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure or sleep apnea [1]. Some plans add a lifetime or annual dollar cap on weight-management drugs, so read the fine print.
Start by pulling your benefits booklet or logging into your insurer's portal. Search for terms like weight management, anti-obesity, or GLP-1. If you find Zepbound or tirzepatide listed with a prior-authorization note, you are in good shape and just need to work the forms.
vs Ozempic: Coverage Comparison
Ozempic carries a type 2 diabetes label, which is why it wins public listings that Zepbound cannot. On several provincial formularies, Ozempic is covered for diabetes with criteria, while Zepbound sits outside public plans entirely because of its weight-loss label. If you have diabetes, a diabetes-labelled drug may open a coverage door that a weight-loss drug keeps shut. Our Zepbound vs Ozempic comparison walks through the tradeoffs, and it is a conversation worth having with your prescriber.
Costs With and Without Insurance
Here is what the pen costs you in each scenario, per four-week supply.
| Your situation | What a 4-week pen costs |
|---|---|
| Private plan approves it, plus myZepbound card | About $30 average copay [3] |
| Private plan approves it, no card | Your plan copay, often $0 to $100 by plan |
| No coverage, cash, 2.5 or 5 mg | $300 list [4] |
| No coverage, cash, 12.5 or 15 mg | $540 list [4] |
The Lilly list prices took effect on December 29, 2025 and run $300 for the two starter doses, $420 for the middle pair, and $540 for the top pair [4]. A private plan that approves the claim can drop that to a modest copay.
A Cheaper Option: Generic Semaglutide
There is no generic Zepbound. Tirzepatide is under patent, so no cheaper copy exists and none is expected for years. Generic semaglutide is a different molecule doing a similar job. It is the generic version of Ozempic, a weekly injection, and if cost is the deciding factor, it now sells for about $88 to $120 a month at Canadian pharmacies. MyRocky offers it online at $149 a month all-in, consult and follow-up included. Our generic semaglutide guide compares pharmacy prices country-wide. Ask your prescriber before switching molecules, since tirzepatide and semaglutide dose differently and results vary person to person.
Prior Authorization: Step by Step
Prior authorization is the paperwork gate between you and a covered pen. It sounds intimidating, but it is a sequence you can work through. Here is the play.
- Confirm the drug is on your plan: log into your insurer's portal or call the number on your benefits card and ask whether tirzepatide or Zepbound is eligible with prior authorization.
- Get the form: your insurer supplies a prior-authorization form, often called a special authorization or weight-management form. Download it or ask them to email it.
- Have your prescriber complete it: they document your BMI, any weight-related conditions, and past treatments. The usual bar is a BMI of 30 or higher, or 27 or higher with a comorbidity [1].
- Submit and track: send the form back, note the reference number, and follow up in a week if you have not heard. Approvals often come with a review date, so mark your calendar to renew.
- Lean on the manufacturer program: the myZepbound program includes prior-authorization and reimbursement navigation help, which takes some of the paperwork off your plate. Our savings card guide covers it.
Common Denial Reasons and How to Fight Back
A denial is not the end. Most rejections come from a handful of fixable issues, and insurers have appeal processes. Work the list below before you give up on coverage.
- Missing documentation: the most common cause. Ask exactly what was missing, then have your prescriber add the BMI figure, comorbidity notes, or lab values and resubmit.
- Plan excludes weight-loss drugs: if your plan simply does not cover the category, an appeal will not change that. Check whether a health spending account can pick up the cost instead.
- BMI just under threshold: if you sit at a BMI of 27 or 28 with no documented comorbidity, work with your prescriber to record any qualifying condition accurately.
- Formal appeal: every insurer has an appeals process. A letter of medical necessity from your prescriber, plus the trial data, moves the needle more often than people expect.
The Medical Expense Tax Credit
Even with no drug-plan coverage, tax time can hand some money back. Prescribed Zepbound counts as an eligible medical expense for the Medical Expense Tax Credit on line 33099 of your federal return [5]. Keep every pharmacy receipt, because a full year of pen purchases adds up fast. The CRA eligible expenses page spells out the rules and the threshold that applies to your income.
Online Providers Cost Comparison
If coverage falls through, telehealth is how many Canadians get treated without waiting on a family doctor. One accuracy note: MyRocky prescribes and fills Zepbound (tirzepatide) online, plus generic semaglutide from $149 a month as a lower-cost option. Our full MyRocky review covers the service end to end.
| Provider | Tirzepatide access | Consult fee | Get started |
|---|---|---|---|
| MyRocky ⭐ Top Pick | Zepbound (tirzepatide), plus generic semaglutide from $149/month | $99 one time, includes lab work | Visit MyRocky |
| Felix Health | GLP-1 weight-loss program; confirm current Zepbound availability at intake | Program fees vary by plan | Visit Felix |
| Maple | General telehealth; the doctor can send a prescription to your local pharmacy | Per-visit fee | Book through the Maple app |
| Hims & Hers Canada | Weight-loss GLP-1 program, confirm tirzepatide | Consult and program fees vary | Read our Hims review |
| Phoenix | Men's telehealth for weight-loss GLP-1s, confirm tirzepatide | Consult fees vary | Read our Phoenix review |
| Raven | Women's telehealth for weight-loss GLP-1s, confirm tirzepatide | Consult fees vary | Read our Raven review |
A consult fee never changes the pen price at the pharmacy or what your insurer will approve. You are paying for a fast prescription, not a discount on the drug.
Does OHIP or any provincial plan cover Zepbound?
No. As of mid-2026, no provincial public plan covers Zepbound for weight loss. That includes OHIP and every other provincial formulary across Canada. Public plans exclude weight-loss-only medications. If you have private workplace benefits, that is your better bet, since some employer plans do include GLP-1 coverage under the right conditions.
Will my work benefits cover Zepbound?
Maybe. Around 31% of Canadian employer plans include some GLP-1 weight-loss coverage, so it depends on your employer. Most plans that do cover it want prior authorization, usually a BMI of 30 or higher, or 27 plus a weight-related condition. Check your benefits booklet or ask your HR contact directly.
What is prior authorization?
Prior authorization is approval your insurer wants before it pays for Zepbound. Your prescriber submits paperwork showing you meet the plan's rules, often a BMI threshold plus a documented weight-related condition. Approval can take a few days to a few weeks. The myZepbound program helps with this paperwork if you get stuck.
Is Zepbound covered for sleep apnea?
Zepbound is approved in Canada for obstructive sleep apnea in adults with obesity, alongside its weight-management use. Approval and insurance coverage are two different things, though. A sleep apnea diagnosis might strengthen a private prior-authorization request, but no provincial public plan pays for Zepbound yet. Confirm the details with your own insurer.
Does BC PharmaCare cover it yet?
Not yet. BC PharmaCare has Zepbound formally under review under tirzepatide submission #4166, and the outcome is still pending. Until a decision lands, British Columbia residents pay cash or rely on private benefits. Keep an eye on the PharmaCare drug info page for updates, since the review status can change.
Can I claim Zepbound on my taxes?
Yes. Prescribed Zepbound counts toward the Medical Expense Tax Credit on CRA line 33099. Keep your pharmacy receipts, since you claim the portion you paid out of pocket above the annual threshold. This will not make Zepbound free, but it can shave a real amount off your yearly tax bill.
What BMI do insurers require?
Most private plans that cover Zepbound want a BMI of 30 or higher, or 27 or higher with a weight-related condition like type 2 diabetes or high blood pressure. Those same thresholds match Zepbound's approved use in Canada. Your prescriber documents this during the prior-authorization step to make your case.
This article is informational and is not a substitute for medical advice from your prescribing clinician. Always confirm pricing and coverage directly with the pharmacy and your insurer before filling.
Sources
- Are weight-loss medications covered in Canada?: PolicyAdvisor data on employer plan GLP-1 coverage rates and prior authorization criteria.
- Tirzepatide (Zepbound) drug information sheet, submission 4166: Government of British Columbia PharmaCare review record for the pending Zepbound decision.
- Zepbound KwikPen patient support and savings FAQ: Lilly Canada details on the myZepbound program pricing, insured copay, and enrollment.
- Eli Lilly & Co. cuts price of popular diabetes and weight-loss drugs in Canada: The Globe and Mail report on the Zepbound list prices effective December 29, 2025.
- Lines 33099 and 33199, eligible medical expenses: Canada Revenue Agency rules for the Medical Expense Tax Credit.
- Zepbound KwikPen approved and available in Canada: Lilly Canada launch announcement via Newswire confirming approval and availability.